Does Testosterone Salvage PDE5i Non-Responders? A Scoping Review
Open Access
- 22 February 2023
- journal article
- research article
- Published by MDPI AG in Endocrines
- Vol. 4 (1) , 117-127
Abstract
Erectile physiology, in order to function normally, requires the complex coordination of endocrine, neurocognitive, neuromuscular and vascular mechanisms. Testosterone (T) influences male sexuality as well as penile erections at multiple levels, including a direct influence on the nitric oxide synthase (NOS)/cGMP/phosphodiesterase 5 pathway in the penis. However, the precise role of testosterone replacement (TRT) to “salvage” men with mixed ED failing phosphdiesterase-5 inhibitors (PDE5i) remains unclear. We conducted a scoping review identifying the rationale for TRT in ED failing PDE5i, and we critically discuss clinical trials that have examined TRT in the setting of PDE5i use. Overall, TRT replacement appears to be well tolerated and may enhance the response to PDE5i and quality of life, particularly for men with mixed ED, and particularly among men with very low levels of testosterone. However, most of the available literature examines concurrent TRT alone or simultaneous TRT + PDE5i usage, without necessarily selecting for PDE5i failure cases. The present studies are limited to heterogenous studies with small sample sizes, without an exact predominant etiologic factor causing ED. Furthermore, studies showing the most benefit are non-placebo-controlled trials; however, the correction of more profound hypogonadism may lead to an improved response to PDE5i. Stronger conclusions would require properly selected patient populations and larger placebo-controlled RCTs.Keywords
This publication has 55 references indexed in Scilit:
- Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety databaseInternational Journal Of Clinical Practice, 2009
- Testosterone and Erectile Function: From Basic Research to a New Clinical Paradigm for Managing Men with Androgen Insufficiency and Erectile DysfunctionEuropean Urology, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Dose—Response Relationship Between Testosterone and Erectile Function: Evidence for the Existence of a Critical ThresholdJournal of Andrology, 2006
- Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil aloneInternational Journal Of Impotence Research, 2006
- Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunctionBJU International, 2005
- RANDOMIZED STUDY OF TESTOSTERONE GEL AS ADJUNCTIVE THERAPY TO SILDENAFIL IN HYPOGONADAL MEN WITH ERECTILE DYSFUNCTION WHO DO NOT RESPOND TO SILDENAFIL ALONEJournal of Urology, 2004
- Mechanisms of action of PDE5 inhibition in erectile dysfunctionInternational Journal Of Impotence Research, 2004
- Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy aloneThe Aging Male, 2003
- The effects of testosterone on the cavernous tissue and erectile functionWorld Journal of Urology, 1997